Cargando…
Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes
OBJECTIVE: To explore whether treatment with pioglitazone was associated with risk of incident cancer at the 10 most common sites (prostate, female breast, lung/bronchus, endometrial, colon, non-Hodgkin lymphoma [NHL], pancreas, kidney/renal pelvis, rectal, and melanoma). RESEARCH DESIGN AND METHODS...
Autores principales: | Ferrara, Assiamira, Lewis, James D., Quesenberry, Charles P., Peng, Tiffany, Strom, Brian L., Van Den Eeden, Stephen K., Ehrlich, Samantha F., Habel, Laurel A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064052/ https://www.ncbi.nlm.nih.gov/pubmed/21447664 http://dx.doi.org/10.2337/dc10-1067 |
Ejemplares similares
-
Response to: Analyses Using Time-Dependent Pioglitazone Usage in Cox Models May Lead to Wrong Conclusions About Its Association With Cancer
por: Habel, Laurel, et al.
Publicado: (2011) -
Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone: Interim report of a longitudinal cohort study
por: Lewis, James D., et al.
Publicado: (2011) -
Cohort Study of Insulin Glargine and Risk of Breast, Prostate, and Colorectal Cancer Among Patients With Diabetes
por: Habel, Laurel A., et al.
Publicado: (2013) -
Patients Diagnosed With Diabetes Are at Increased Risk for Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Fibrosis, and Pneumonia but Not Lung Cancer
por: Ehrlich, Samantha F., et al.
Publicado: (2010) -
Impact of type 2 diabetes on lower urinary tract symptoms in men: a cohort study
por: Van Den Eeden, Stephen K, et al.
Publicado: (2013)